138 related articles for article (PubMed ID: 30358904)
41. Diseases and clinical applications of the calcium sensing receptor.
Alon US
Pediatr Endocrinol Rev; 2007 Sep; 5(1):482-8. PubMed ID: 17925789
[TBL] [Abstract][Full Text] [Related]
42. An acquired hypocalciuric hypercalcemia autoantibody induces allosteric transition among active human Ca-sensing receptor conformations.
Makita N; Sato J; Manaka K; Shoji Y; Oishi A; Hashimoto M; Fujita T; Iiri T
Proc Natl Acad Sci U S A; 2007 Mar; 104(13):5443-8. PubMed ID: 17372216
[TBL] [Abstract][Full Text] [Related]
43. A Neonatal Case of Autosomal Dominant Hypoparathyroidism without Mutation of the CASR Gene.
Miyata I; Yoshikawa H; Kurokawa N; Kanno K; Hayashi Y; Eto Y
Clin Pediatr Endocrinol; 2008; 17(1):17-22. PubMed ID: 24790357
[TBL] [Abstract][Full Text] [Related]
44. Translational implications of the parathyroid calcium receptor.
Stewart AF
N Engl J Med; 2004 Jul; 351(4):324-6. PubMed ID: 15269311
[No Abstract] [Full Text] [Related]
45. Analysis of AP2S1, a calcium-sensing receptor regulator, in familial and sporadic isolated hypoparathyroidism.
Lambert AS; Grybek V; Francou B; Esterle L; Bertrand G; Bouligand J; Guiochon-Mantel A; Hieronimus S; Voitel D; Soskin S; Magdelaine C; Lienhardt A; Silve C; Linglart A
J Clin Endocrinol Metab; 2014 Mar; 99(3):E469-73. PubMed ID: 24423332
[TBL] [Abstract][Full Text] [Related]
46. Calcium-sensing receptor expression and signalling in human parathyroid adenomas and primary hyperplasia.
Corbetta S; Mantovani G; Lania A; Borgato S; Vicentini L; Beretta E; Faglia G; Di Blasio AM; Spada A
Clin Endocrinol (Oxf); 2000 Mar; 52(3):339-48. PubMed ID: 10718832
[TBL] [Abstract][Full Text] [Related]
47. A syndrome of hypocalciuric hypercalcemia caused by autoantibodies directed at the calcium-sensing receptor.
Kifor O; Moore FD; Delaney M; Garber J; Hendy GN; Butters R; Gao P; Cantor TL; Kifor I; Brown EM; Wysolmerski J
J Clin Endocrinol Metab; 2003 Jan; 88(1):60-72. PubMed ID: 12519831
[TBL] [Abstract][Full Text] [Related]
48. [Familial hypoparathyroidism due to activating mutations in the calcium-sensing receptor gene].
Watanabe T; Minagawa M
Nihon Rinsho; 2002 Feb; 60(2):331-7. PubMed ID: 11857922
[TBL] [Abstract][Full Text] [Related]
49. Functional autoantibodies cause hypoparathyroidism.
Husebye ES
J Clin Endocrinol Metab; 2009 Dec; 94(12):4655-7. PubMed ID: 19959750
[No Abstract] [Full Text] [Related]
50. Long-Term Parathyroid Hormone 1-34 Replacement Therapy in Children with Hypoparathyroidism.
Winer KK; Kelly A; Johns A; Zhang B; Dowdy K; Kim L; Reynolds JC; Albert PS; Cutler GB
J Pediatr; 2018 Dec; 203():391-399.e1. PubMed ID: 30470382
[TBL] [Abstract][Full Text] [Related]
51. Persistent hypocalcaemia in a Chinese girl due to a novel de-novo activating mutation of the calcium-sensing receptor gene.
Wong WC; Lam CW; Tong SF; Tong CT
Hong Kong Med J; 2011 Apr; 17(2):157-60. PubMed ID: 21471599
[TBL] [Abstract][Full Text] [Related]
52. Novel calcium-sensing receptor cytoplasmic tail deletion mutation causing autosomal dominant hypocalcemia: molecular and clinical study.
Obermannova B; Sumnik Z; Dusatkova P; Cinek O; Grant M; Lebl J; Hendy GN
Eur J Endocrinol; 2016 Apr; 174(4):K1-K11. PubMed ID: 26764418
[TBL] [Abstract][Full Text] [Related]
53. Insights into calcium-sensing receptor trafficking and biased signalling by studies of calcium homeostasis.
Gorvin CM
J Mol Endocrinol; 2018 Jul; 61(1):R1-R12. PubMed ID: 29599414
[TBL] [Abstract][Full Text] [Related]
54. A novel homozygous mutation in the parathyroid hormone gene (PTH) in a girl with isolated hypoparathyroidism.
Ertl DA; Stary S; Streubel B; Raimann A; Haeusler G
Bone; 2012 Sep; 51(3):629-32. PubMed ID: 22722080
[TBL] [Abstract][Full Text] [Related]
55. Medical Hypoparathyroidism.
Siraj N; Hakami Y; Khan A
Endocrinol Metab Clin North Am; 2018 Dec; 47(4):797-808. PubMed ID: 30390814
[TBL] [Abstract][Full Text] [Related]
56. Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study.
Clarke BL; Kay Berg J; Fox J; Cyran JA; Lagast H
Clin Ther; 2014 May; 36(5):722-36. PubMed ID: 24802860
[TBL] [Abstract][Full Text] [Related]
57. Diseases associated with calcium-sensing receptor.
Vahe C; Benomar K; Espiard S; Coppin L; Jannin A; Odou MF; Vantyghem MC
Orphanet J Rare Dis; 2017 Jan; 12(1):19. PubMed ID: 28122587
[TBL] [Abstract][Full Text] [Related]
58. Novel mutations associated with inherited human calcium-sensing receptor disorders: A clinical genetic study.
García-Castaño A; Madariaga L; Pérez de Nanclares G; Ariceta G; Gaztambide S; Castaño L
Eur J Endocrinol; 2019 Jan; 180(1):59-70. PubMed ID: 30407919
[TBL] [Abstract][Full Text] [Related]
59. Hyperparathyroidism in a patient with autoimmune polyglandular syndrome.
Pelletier-Morel L; Fabien N; Mouhoub Y; Boitard C; Larger E
Intern Med; 2008; 47(21):1911-5. PubMed ID: 18981636
[TBL] [Abstract][Full Text] [Related]
60. Antiidiotypic PTH antibodies as a cause of elevated immunoreactive parathyroid hormone in idiopathic hypoparathyroidism, a second case: another manifestation of autoimmune endocrine disease?
McElduff A; Lackmann M; Wilkinson M
Calcif Tissue Int; 1992 Aug; 51(2):121-6. PubMed ID: 1422950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
